Project Grant HT94252510230
Award Date
6/15/25
Completion Date
6/14/29
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
This $1,146,270 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Wisconsin System to target a lipid kinase regulator of nuclear Akt in breast cancer. The project aims to transform health care for Service Members and the American public through innovative and impactful research, with a focus on medical solutions for the battlefield. The grant will fund research activities at the University of...
This federal Project Grant award of $1,146,270.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Wisconsin System. The grant supports research targeting a lipid kinase regulator of nuclear AKT in breast cancer, with a performance period from July 15, 2023 to July 14, 2026. The University of Wisconsin System, through its University of Wisconsin - Madison division, will conduct this biomedical research to...
The University of Wisconsin System has been awarded a $1,555,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, with a performance period from April 15, 2025 to April 14, 2029, will fund research to develop population modeling techniques to optimize equitable ovarian cancer outcomes. This work supports the program's objective of transforming healthcare for military service members and the general public through...
The University of Wisconsin-Madison will receive $1,145,080 under a three-year Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research from February 2021 to January 2024 to therapeutically target a lipid kinase regulator of mutant p53 in breast cancer. Through this award provided by the CFDA 12.420 program, the University of Wisconsin-Madison aims to investigate medical solutions for the battlefield and...
The Defense Health Agency has awarded a $862,751 Project Grant to the University of Wisconsin-Milwaukee (UWM) under the Military Medical Research and Development program (CFDA 12.420). The grant, effective June 1, 2024 through May 31, 2027, will fund a research project to study the "Impact of Recent Childbirth on Breast Cancer Prognosis and Tumor Molecular Phenotypes Among Young Black and White Women." This grant supports UWM's ongoing biomedical research initiatives focused on...
This $785,833 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports advanced research to target immunotherapy-resistant lesions and eradicate oligometastatic prostate cancer. Awarded to the University of Wisconsin System, the research aims to transform healthcare for military service members and the broader public by investigating innovative approaches to disease prevention, diagnosis,...
This federal Project Grant award, valued at $155,500.00 and provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is for the University of Wisconsin System to develop a model to study tumor-normal cell interaction in vitro for high-throughput drug screening. The research aims to transform healthcare for military service members and the broader public through innovative biomedical investigations. The one-year project will run from...
The University of Wisconsin System was awarded a $995,076 project grant by the U.S. Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support the development of new agents for the treatment of hormone receptor positive and HER2 positive breast cancer. The grant was awarded on Dec 15, 2023 and is scheduled for completion on Dec 14, 2026. As part of this project, the University of Wisconsin System has sub-awarded funding to Loyola University of...
This $777,500 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program will support multiomic analysis of liquid biopsies for biomarker discovery and therapeutic targeting at the University of Wisconsin - Madison. The 3-year project, running from June 1, 2025 to May 31, 2028, will leverage the university's expertise in medical research and analysis to advance innovative approaches to disease prevention,...
This federal Project Grant award of $459,747.00, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research at the University of Wisconsin-Madison to define the effect of copy number amplification on the regulation of oncogenes in high-grade serous ovarian carcinoma. The research will examine the contributions of superenhancers at the 8q22 region, with the goal of advancing scientific understanding and potential treatment...